Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Operating Margin (2016 - 2025)

Historic Operating Margin for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to 684.54%.

  • Firefly Neuroscience's Operating Margin rose 122488000.0% to 684.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 1450.52%, marking a year-over-year increase of 96102900.0%. This contributed to the annual value of 618.07% for FY2023, which is 5689100.0% down from last year.
  • As of Q3 2025, Firefly Neuroscience's Operating Margin stood at 684.54%, which was up 122488000.0% from 546.49% recorded in Q2 2025.
  • Over the past 5 years, Firefly Neuroscience's Operating Margin peaked at 6247.27% during Q4 2024, and registered a low of 12933.33% during Q3 2024.
  • Over the past 5 years, Firefly Neuroscience's median Operating Margin value was 55.99% (recorded in 2022), while the average stood at 2409.7%.
  • Examining YoY changes over the last 5 years, Firefly Neuroscience's Operating Margin showed a top increase of 144946400bps in 2024 and a maximum decrease of -126143600bps in 2024.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Operating Margin stood at 110.99% in 2021, then skyrocketed by 54bps to 51.38% in 2022, then plummeted by -15951bps to 8247.37% in 2023, then soared by 176bps to 6247.27% in 2024, then plummeted by -111bps to 684.54% in 2025.
  • Its Operating Margin was 684.54% in Q3 2025, compared to 546.49% in Q2 2025 and 4802.33% in Q1 2025.